Paris, on December 16, 2019. Jeantet advised Euromédis Groupe, a company listed on the regulated market of Euronext Paris which is a French major player in the medical devices and home medical assistance sectors, on its convertible bonds issuance with shareholders’ preferential subscription rights.
Following the subscription period, opened from November 25 to December 6, 2019, the issuance was oversubscribed up to 128%. In the framework of this transaction, 592,260 convertible bonds were subscribed at a unit price of €4.80, representing a total nominal amount of around €2.8 million.
Settlement-delivery of the convertible bonds, which will not be admitted to trading on a financial market, occurred on December 16, 2019.
The main purpose of the convertible bonds issuance is to provide financings for the company’s investments and its working capital requirements.
Jeantet (deal counsel): Cyril Deniaud, partner, and Clémence Gagneux, associate (Corporate / Capital market law department).